How soon can you refill your GLP-1 medication?

Dr. Linda's take

"When can I actually refill this?" is one of the most common questions I hear from patients on a weekly GLP-1 or GIP medication, and it is a fair one. The honest answer is that refill timing is not one question, it is two. One part comes from the medication itself, spelled out in the drug's own FDA label. The other part comes from your insurance plan and your pharmacy, and it has nothing to do with the label at all. People often assume a single rule governs both, and that mix-up is where most of the confusion starts. This piece lays out the general framework. For the exact numbers on a specific medication, see the Zepbound and Mounjaro breakdowns linked below.

How does weekly GLP-1 and GIP dosing work in general?

Most of the injectable medications in this class, including tirzepatide (sold as Zepbound for weight management and Mounjaro for type 2 diabetes) and semaglutide (sold as Wegovy and Ozempic), are dosed on a once-weekly schedule rather than daily. Patients typically start at a low dose and move up in steps over a period of months toward a maintenance dose, with each step spaced out by a minimum number of weeks set by the drug's own label. Because dosing is weekly rather than daily, a single early or late injection has a much bigger effect on the calendar than missing one dose of a daily pill would, which is exactly why refill and re-dosing questions come up so often with this medication class.

What do FDA labels generally say about a missed or late dose?

Each of these medications has its own FDA-approved prescribing information, and the missed-dose instructions are not identical across every drug in the class, so it is worth checking the specific label rather than assuming. For tirzepatide specifically, both Zepbound's and Mounjaro's current FDA labels use matching language. The label instructs that if a dose is missed, it can still be given as soon as possible within 4 days, or 96 hours, of the missed dose. If more than 4 days have passed, the label instructs skipping that missed dose entirely and administering the next dose on the regularly scheduled day, then resuming the normal weekly rhythm from there. Both labels also note that the day of the week for dosing can be changed if needed, as long as at least 3 days, or 72 hours, separate the two doses. These specifics come from the tirzepatide labels; semaglutide's own label sets its own missed-dose window, which is a separate question from what is covered here.

Why does refill timing depend on two different things?

The first is the drug's own dosing schedule, which is fixed and spelled out in the FDA label, as described above. The second is your insurance plan and pharmacy's refill rules, which are administrative and financial, not clinical. A pharmacy benefit typically will not release a paid refill until you are close to running out of your current supply, and exactly how close varies by plan, by pharmacy, and sometimes by state pharmacy regulations. There is no single fixed number of days that applies to every plan, so a specific day-count you hear from another patient or see online may not match your own coverage. If a refill seems to be arriving earlier or later than expected, the drug's own schedule and the pharmacy's refill window are two separate things to check, and only your plan or pharmacy can tell you where your specific refill window sits.

Does dose titration change how refills line up?

It can. Early in treatment, many patients move to a new, often higher, dose every four weeks or so as directed by their clinician and the label's titration schedule. Since each new dose typically ships as its own prescription strength, a dose change can shift your refill date even when nothing about your weekly injection habit has changed. This is a normal part of starting one of these medications and is worth expecting rather than treating as a scheduling error.

How does Zepbound's refill timing work specifically?

Zepbound has its own titration schedule, its own missed-dose language, and its own practical reasons a refill might land early or late. We cover all of that, sourced directly from Zepbound's FDA label, in how fast can you refill Zepbound?

How does Mounjaro's refill timing work specifically?

Mounjaro is also tirzepatide, but it is a separate FDA-approved product from Zepbound with its own label and its own approved use. We break down Mounjaro's specific schedule and missed-dose guidance in Mounjaro refills: how early can you get one?

Frequently asked questions

How soon can I refill my GLP-1 medication after my last dose?

It depends on which question you are asking. The medication's own schedule is set by its FDA label and is the same for everyone on that drug. The refill availability through your pharmacy is set by your insurance plan and can vary. The Zepbound and Mounjaro articles linked above cover the specific label-based schedules for those two medications.

What happens if I miss a dose of my GLP-1 medication?

Each medication's FDA label spells out its own missed-dose instructions. For tirzepatide products, the label generally allows the dose to be given within a matter of days after the missed date, with a different instruction if more time has passed. The exact window is in the linked Zepbound and Mounjaro articles, and any questions about a specific missed dose are best directed to your clinician or pharmacist.

Does my insurance decide when I can refill, or does the drug label?

Both play a role, but they answer different questions. The label sets the clinical dosing schedule. Your insurance plan and pharmacy set when a paid refill can be released, which is a separate, plan-dependent process.

Do all GLP-1 and GIP medications follow the same refill timing?

No. Each medication has its own FDA-approved label with its own dosing schedule and its own missed-dose instructions. Tirzepatide's two brands, Zepbound and Mounjaro, happen to share very similar label language because they are the same molecule, but semaglutide-based products are governed by a separate label with its own terms.

Where can I find the exact refill window for my medication?

The most reliable source is the medication's own current FDA prescribing information, available through DailyMed or the FDA's own site, or a conversation with your prescribing clinician or pharmacist about your specific plan.

References

1. U.S. Food and Drug Administration / Eli Lilly and Company (2026). ZEPBOUND (tirzepatide) injection, for subcutaneous use, prescribing information (Revised 4/2026), DailyMed. U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b (Accessed 2026-07-12).
2. U.S. Food and Drug Administration / Eli Lilly and Company (2026). MOUNJARO (tirzepatide) injection, for subcutaneous use, prescribing information (Revised 4/2026), DailyMed. U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0 (Accessed 2026-07-12).